Expanded Access to Upadacitinib

NCT04159597 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Crohn Disease
Ulcerative Colitis
Idiopathic Arthritis (Including sJIA, pJIA, or JPsA)
Atopic Dermatitis

Interventions

DRUG: Upadacitinib

Sponsor

AbbVie